Useful resources |
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism (Cochrane Review) ABSTRACT Background: People with venous thromboembolism (VTE) are generally treated for five days with intravenous unfractionated heparin or subcutaneous low-molecular-weight heparin (LMWH) followed by three months of vitamin K antagonists treatment. Treatment with vitam . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |